Urodelia HAS DEVELOPED IN COLLABORATION WITH RESEARCHERS AND PRACTICING VETERINARIANS AN INNOVATIVE AND PATENTED IMMUNOTHERAPY METHOD TO TREAT CANCER IN PETS: APAVAC®
The immune system of a dog with a cancer does not recognize the abnormal proteins produced by the tumor. Using the APAVAC® kit, the veterinary oncologist extracts the neoplastic lymph node and separates abnormal proteins. He injects them back into the ill dog’s body to make its immune system react against these proteins. Its T lymphocytes will then destroy the cancer cells.
APAVAC®’s immunotherapy solution improves the animal’s quality of life during its disease and extends significantly its overall survival compared to dogs undergoing chemotherapy treatment alone. APAVAC® is already used by European veterinary oncologists: APAVAC® is a reference at the Centro Oncologico Veterinario (COV), Italy. Scientific results were published in Clinical Cancer Research in February 2014.
APAVAC®’s immunotherapy solution is a new kind of animal health -treatment. Our sole focus is on solving the medical needs of pets. We are working to bring scientific advances in immune oncology to pets and veterinary medicine.
Urodelia has been selected to attend the Ubistart Galien Tour in July 2014 to set up partnership leading to human healthcare applications worldwide. Human Clinical trials phase I-II are planned in Europe in 2014.
More information ?
Contact us at : firstname.lastname@example.org